Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Peringkat dalam Saham #40953
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Harga Saham
$0.15137669
Kapitalisasi Pasar
$58.28K
Perubahan (1 hari)
11.25%
Perubahan (1 tahun)
6.17%
Negara
VG
Perdagangan CRISM Therapeutics Corporation (CRTX)

Kategori

Harga CRTX dengan kapitalisasi pasar B
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
CRTX
$0.15137669
Kapitalisasi pasar dari CRISM Therapeutics Corporation(CRTX)
Kapitalisasi Pasar: $58.28K
Per August 2026, CRISM Therapeutics Corporation memiliki kapitalisasi pasar sebesar $58.28K. Ini menjadikan CRISM Therapeutics Corporation sebagai perusahaan 40953rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar CRISM Therapeutics Corporation dari 2003 hingga 2026
CRTX dibandingkan dengan 5 teratas stocks paling populer
Harga CRTX Aset B Pasar B Hasil
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$14,149,965 $58.28K
$5.448T +9,347,518,994.09%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$11,489,328 $58.28K
$4.423T +7,589,892,339.23%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$10,806,154 $58.28K
$4.160T +7,138,585,386.14%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$9,515,119 $58.28K
$3.663T +6,285,722,740.82%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$7,509,685 $58.28K
$2.891T +4,960,925,706.37%